A novel asymmetrical anti-HER2/CD3 bispecific antibody exhibits potent cytotoxicity for HER2-positive tumor cells

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, August 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter: 2 X users

patent: 2 patents

Citations

dimensions_citation: 50 Dimensions

Readers on

mendeley: 63 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

IMMUNE CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS AND BISPECIFIC ANTIBODIES AND USES…

Application WO-2023186873-A1

World Intellectual Property Organisation (WIPO)

IMMUNE CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS AND BISPECIFIC ANTIBODIES AND USES…

Application EP-4253418-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.